149
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Serum Collagen Triple Helix Repeat Containing-1 Levels are Related to Radiological Affection and Disease Activity in Rheumatoid Arthritis

ORCID Icon, , , , ORCID Icon, ORCID Icon, , , ORCID Icon & show all
Pages 291-299 | Received 27 Sep 2022, Accepted 16 Nov 2022, Published online: 09 Dec 2022

References

  • Romão VC, Fonseca JE. Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review. Front Med. 2021;8:689698. PMID: 34901047; PMCID: PMC8661097. doi:10.3389/fmed.2021.689698
  • Cush JJ. Rheumatoid arthritis: early diagnosis and treatment. Rheum Dis Clin North Am. 2022;48(2):537–547. doi:10.1016/j.rdc.2022.02.010
  • Rivellese F, Pitzalis C. Cellular and molecular diversity in rheumatoid arthritis. Semin Immunol. 2022:101519. PMID: 35033462. doi:10.1016/j.smim.2021.101519
  • Mucke J, Krusche M, Burmester GR. A broad look into the future of rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2022;14:1759720X221076211. PMID: 35154419; PMCID: PMC8832593. doi:10.1177/1759720X221076211
  • Abdelhafiz D, Baker T, Glascow DA, Abdelhafiz A. Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review. Postgrad Med. 2022:1–10. PMID: 35275765. doi:10.1080/00325481.2022.2052626
  • Kirkness MW, Lehmann K, Forde NR. Mechanics and structural stability of the collagen triple helix. Curr Opin Chem Biol. 2019;53:98–105. PMID: 31606538. doi:10.1016/j.cbpa.2019.08.001
  • LeClair R, Lindner V. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med. 2007. 17(6):202–205. Erratum in: Trends Cardiovasc Med. 2010 Oct;20(7):247. PMID: 17662915. doi:10.1016/j.tcm.2007.05.004
  • Wu Q, Yang Q, Sun H. Role of collagen triple helix repeat containing-1 in tumor and inflammatory diseases. J Cancer Res Ther. 2017;13(4):621–624. PMID: 28901303. doi:10.4103/jcrt.JCRT_410_17
  • Guo B, Yan H, Li L, Yin K, Ji F, Zhang S. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer. J Ovarian Res. 2017;10(1):69. PMID: 29021002; PMCID: PMC5637322. doi:10.1186/s13048-017-0358-8
  • Fu SW, Chen HY, Lin XL, Yang L, Ge ZZ. Collagen triple helix repeat containing 1 promotes tumor angiogenesis in gastrointestinal stromal tumors. Oncol Lett. 2017;14(6):7499–7505. PMID: 29344195; PMCID: PMC5755008. doi:10.3892/ol.2017.7111
  • Liu Y, Abulimiti N, Wang C. Collagen triple helix repeat containing 1 expression in osteosarcoma: a new predictor of prognosis. Ann Clin Lab Sci. 2018;48(3):338–344. PMID: 29970438.
  • Liu Y, Hu T, Li X, et al. Application of collagen triple helix repeat containing-1 and mitotic spindle apparatus antibody in small cell lung cancer diagnosis. J Clin Lab Anal. 2022;36(5):e24412. PMID: 35385156; PMCID: PMC9102652. doi:10.1002/jcla.24412
  • Shekhani MT, Forde TS, Adilbayeva A, et al. Collagen triple helix repeat containing 1 is a new promigratory marker of arthritic pannus. Arthritis Res Ther. 2016;18:171. PMID: 27430622; PMCID: PMC4950773. doi:10.1186/s13075-016-1067-1
  • Jin YR, Stohn JP, Wang Q, et al. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1. Bone. 2017;97:153–167. PMID: 28115279; PMCID: PMC6746321. doi:10.1016/j.bone.2017.01.022
  • Myngbay A, Bexeitov Y, Adilbayeva A, et al. CTHRC1: a new candidate biomarker for improved rheumatoid arthritis diagnosis. Front Immunol. 2019;10:1353. PMID: 31249576; PMCID: PMC6582781. doi:10.3389/fimmu.2019.01353
  • Hu T, Liu Y, Tan L, et al. Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3η protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis. Br J Biomed Sci. 2021;78(2):67–71. PMID: 32813981. doi:10.1080/09674845.2020.1810400
  • Selim ZI, Gamal RM, Araby LA, Badawy ER, Gamal NM. Collagen triple helix repeat containing 1 (CTHRC1) protein: a promising biomarker for evaluation of rheumatoid arthritis patients. Egypt Rheumatol. 2022;44(1):11–14. doi:10.1016/j.ejr.2021.07.003
  • Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. PMID: 20872595. doi:10.1002/art.27584
  • Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. diagnostic and therapeutic criteria committee of the American rheumatism association. Arthritis Rheum. 1986;29:1039–1049. doi:10.1002/art.1780290816
  • Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3–6, 1999. J Rheumatol. 2000;27(9):2185–2192. PMID: 10990232.
  • Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–48. PMID: 7818570. doi:10.1002/art.1780380107
  • Pincus T, Summey JA, Soraci SA, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26(11):1346–1353. doi:10.1002/art.1780261107
  • Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 1999;26:743–745.
  • Dias EM, Lukas C, Landewé R, Fatenejad S, van der Heijde D. Reliability and sensitivity to change of the simple erosion narrowing score compared with the sharp-van der heijde method for scoring radiographs in rheumatoid arthritis. Ann Rheum Dis. 2008;67(3):375–379. PMID: 17644537. doi:10.1136/ard.2007.072785
  • Guo Y, Jiang C, Yao S, et al. CTHRC1 knockdown promotes inflammatory responses partially by p38 MAPK activation in human periodontal ligament cells. Inflammation. 2021;44(5):1831–1842. PMID: 33846931. doi:10.1007/s10753-021-01461-8
  • Li R, Tian C, Postlethwaite A, et al. Rheumatoid arthritis and periodontal disease: what are the similarities and differences? Int J Rheum Dis. 2017;20(12):1887–1901. PMID: 29341486. doi:10.1111/1756-185X.13240
  • Tai Y, Zhu Y, Mei D, et al. IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-κB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein. Int Immunopharmacol. 2021;101(Pt A):108261. PMID: 34688134. doi:10.1016/j.intimp.2021.108261
  • Elshabrawy HA, Chen Z, Volin MV, Ravella S, Virupannavar S, Shahrara S. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis. 2015;18(4):433–448. PMID: 26198292; PMCID: PMC4879881. doi:10.1007/s10456-015-9477-2
  • Miao CG, Yang YY, He X, et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal. 2013;25(10):2069–2078. PMID: 23602936. doi:10.1016/j.cellsig.2013.04.002
  • Kudryavtseva E, Forde TS, Pucker AD, Adarichev VA. Wnt signaling genes of murine chromosome 15 are involved in sex-affected pathways of inflammatory arthritis. Arthritis Rheum. 2012;64(4):1057–1068. PMID: 22005949; PMCID: PMC3288823. doi:10.1002/art.33414
  • Chen G, Wang D, Zhao X, et al. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling. Cancer Cell Int. 2017;17:118. PMID: 29234238; PMCID: PMC5721693. doi:10.1186/s12935-017-0469-8
  • He W, Zhang H, Wang Y, et al. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9. BMC Cancer. 2018;18(1):400. PMID: 29631554; PMCID: PMC5891957. doi:10.1186/s12885-018-4317-6
  • Peng D, Wei C, Zhang X, et al. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers. Cancer Cell Int. 2021;21(1):566. PMID: 34702252; PMCID: PMC8549344. doi:10.1186/s12935-021-02266-3